---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-126342"
form_type: "8-K"
ticker: "KYTX"
cik: "0001994702"
company_name: "Kyverna Therapeutics, Inc."
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T01:20:30.574436+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Kyverna Q3 net loss $34.3M; CMO James Chung resigns effective Nov 22

## Summary
- Net loss of $34.3M ($0.80 per share) vs. $15.5M loss in prior-year quarter.
- Cash, equivalents and marketable securities $321.6M as of Sep 30, 2024.
- CMO James Chung, M.D., Ph.D. resigns effective Nov 22; search for replacement underway.
- CEO Warner Biddle appointed; Board adds Christi Shaw and Mert Aktar.
- KYV-101 advances: Phase 2 dosing in myasthenia gravis; RMAT and Orphan Drug designations in multiple indications.

## SEC filing metadata
- accession: 0000950170-24-126342
- form_type: 8-K
- ticker: KYTX
- cik: 0001994702
- company_name: Kyverna Therapeutics, Inc.
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1994702/000095017024126342/0000950170-24-126342-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1994702/000095017024126342/kytx-20241108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-126342
- JSON: https://secwatch.observer/filing/0000950170-24-126342.json
- Plain text: https://secwatch.observer/filing/0000950170-24-126342.txt

## Key facts
- Executive change
  James Chung resigned as Chief Medical Officer at Kyverna Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On November 8, 2024, James Chung, M.D., Ph.D., Chief Medical Officer of the Company, resigned from the Company, to be effective as of November 22, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1994702/000095017024126342/0000950170-24-126342-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.